CBTF Dream and Promise Awards 2019 by D. Scott Smith

The Children’s Brain Tumor Foundation, Joseph Chan, Stephen Downey, Sravan K. Emany, Stuart M. Essig, PhD, Robert Millham, Dan Reuvers, Joseph P. Riccardo, Jr., Craig M. Robertson, Steven Scebelo, Anthony G. Viscogliosi and the Benefit Committee Welcome you to the

17th Annual

Dream & Promise Awards Benefit HONORING Bernadine R. Donahue, MD Vice Chairman and Clinical Director of the Department of Radiation Oncology Maimonides Cancer Center Clinical Associate Professor of the Department of Radiation Oncology NYU Langone Health Clinical Associate Professor Downstate Medical Center will receive the Pioneer Award for Radiation Oncology Viscogliosi Brothers, LLC will be honored with the Dream & Promise Award

MISTRESS OF CEREMONIES Arielle Jacobs, Actress currently starring on Broadway as Princess Jasmine in Disney’s Aladdin

Monday, June 17, 2019 583 Park Avenue

at 64th Street and Park Avenue in Manhattan Proceeds from the evening will be directed to the Children’s Brain Tumor Foundation. Improving the treatment, quality of life and the long-term outlook for children and families affected by a brain or spinal cord tumor.

Message from the Foundation Dear Friends,

All of this and more was possible only because of you.

Last year, Children’s Brain Tumor Foundation marked 30 years in the fight against pediatric brain and spinal cord tumors. This year, with nary a pause in our momentum, we gather again with you, our unfaltering compatriots, to keep the fight going. Generous with your time, your money, your love and energy, no cause could have better allies and no scourge fiercer opponents. We gather for this 17th Annual Dream & Promise Awards Benefit to celebrate the successes of the previous year by gathering the funding needed to make this year even better. With you by our side, we have no doubt new treatments, new care and new survivors await. In its 31-year history, Children’s Brain Tumor Foundation has raised $10.5 million for scientific grants and over $650,000 for professional training and clinical fellowships in pediatric neuro-oncology. The money we raise is essential, for our enemy is strong. The deadliest childhood cancer, pediatric brain and spinal cord tumors attack nearly 5,000 children each year. The tumors are insidious, often misdiagnosed, mimicking the symptoms of other ailments, destroying in secret. A full third of children diagnosed with tumors will not survive more than five years. Where the tumors don’t take lives, they steal childhoods and even futures. In 2009, CBTF, with funding from Licensing International (formerly LIMA), created the Children’s Brain Tumor Tissue Consortium. Partnered with 16 member institutions around the globe, it remains the largest tumor biorepository in the world. Last year, CBTTC launched the Pediatric Brain Tumor Atlas, a never-before-possible open-access, collaborative and cloud-based database of more than 2,500 childhood brain tumor samples. This May, more datasets were added and more will follow. What this accomplishment means for accelerated discovery is tremendous.

2 | Dream & Promise Awards Benefit 2019

This evening you will meet a few special allies, like you, dedicated to finding the cure. We are proud to honor Bernadine R. Donahue, MD, Vice Chairman and Clinical Director of the Department of Radiation Oncology, Maimonides Cancer Center; Clinical Associate Professor for the Department of Radiation Oncology, NYU Langone Health; and Clinical Associate Professor at Downstate Medical Center, with the Pioneer Award for Radiation Oncology. A one-woman vanguard pairing the latest technology with the most personal treatment, Dr. Donahue has set the gold standard for patient care.

Dedicated to fueling the discoveries filling this atlas, in 2018 CBTF awarded CBTTC member Children’s Hospital of Philadelphia $150,000, and awarded $75,000 each to researchers at Boston’s Children’s Hospital, Children’s National Health System and Seattle Children’s Hospital. Because care is as essential as research, Children’s Brain Tumor Foundation revamped its website allowing for faster access connecting parents and children to the information and care communities they need. CBTF’s signature program, the Family-2-Family Network, launched a sibling mentor program, adding a new dimension to our work connecting trained parent, survivor, and sibling mentors with families in need. This summer will see the further addition of online support groups for the parents of younger children and new face-to-face programs in Colorado, Illinois and Ohio. As our online programs grow, so do our in-person offerings. Last year’s included Adolescent and Teen Adventures and Meet Ups in Boston, Philadelphia, New Jersey and New York. We sponsored the 5th Annual Just Us Retreat, the only father/ survivor retreat in the country, and, with Camp-Mak-A-Dream, held three, six-day Heads Up Conferences, the only week-long conference in the United States addressing the needs of brain tumor survivors.

Our Dream & Promise Award recipient, Viscogliosi Brothers, LLC, has been a constant and generous supporter of Children’s Brain Tumor Foundation. Charitable work is part of their overall mission to finance newer and better services and technology for the medical community. Their contributions have allowed for startling innovations in the tools needed to fight pediatric brain and spinal cord tumors, among many other previously unmet clinical needs. Integral to this event for many years, their support has indeed helped dreams come true and promises be met.

Without people willing to freely give themselves to the cause, an event of tonight’s magnitude could never happen. Such people are our event Co-Chairs, Joseph Chan, Stephen Downey, Sravan K. Emany, Stuart M. Essig, PhD, Robert Millham, Dan Reuvers, Joseph P. Riccardo, Jr., Craig M. Robertson, Steven Scebelo, and Anthony G. Viscogliosi. Michele G. Buck, President and CEO of The Hershey Company and a loyal former co-chair of this event, has also helped in myriad ways. We thank you deeply for what you’ve done. What happens tonight will set the stage for another year of Children’s Brain Tumor Foundation’s crucial work. Every donation brings relief to another parent collapsing under the weight of grief, light to another child lost in the shadow of fear. Together let us be lifters of weight and bringers of light, that next year we may meet again with even more to celebrate. Sincerely, Lionel Leventhal Board Chairman Children’s Brain Tumor Foundation

Such worthy proceedings demand a worthy host and Arielle Jacobs more than meets the criteria. An accomplished actress and singer, she currently stars as Princess Jasmine in the smash-hit Broadway musical, Aladdin. Ms. Jacobs made her debut starring opposite Lin-Manuel Miranda in the final cast of In The Heights and has since established herself as Broadway royalty. Recently releasing her debut solo album, we are honored to have her lead the evening and perhaps even offer a bit of song.

Dream & Promise Awards Benefit 2019 | 3

Message from the Benefit Co-Chairs Dear Friends, The invitation to join Children’s Brain Tumor Foundation in their important work is a gift, and by your presence tonight we know you feel the same way. 31 years strong, the Foundation has changed the face of pediatric brain and spinal cord tumor care, delivering on a promise to bring advancements where they were rare and hope where despair ruled. What was an unwavering death sentence when the Foundation began, now is more often survivable in large part because of this organization, obstinate in the face of despair. With nearly 5,000 children and teens diagnosed with brain and spinal cord tumors every year, with a full third of them gone within five years of diagnosis, with over 28,000 survivors in the United States alone fighting to find normal in a world for so many years foreign to them, with families swimming in grief and others praying for the advancements necessary to save their children, such obstinance requires an army. Generous beyond words, you are that army. Tonight, we celebrate Children’s Brain Tumor Foundation, cheer for the children and families refusing to let despair cloud their hearts and give all we can to disperse the darkness. We celebrate what you’ve done by giving you the chance to do more, because we know this is what you want.

Our children are the future… Integra LifeSciences is proud to support CBTF’s children and their families afflicted with brain & spinal cord tumors by co-chairing the 17th Annual Dream and Promise Awards Benefit and their goal to raise $1,100,000. Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation or its subsidiaries in the United States and/or other countries. ©2019 Integra LifeSciences Corporation. All rights reserved.

4 | Dream & Promise Awards Benefit 2019

integralife.com

You stand tall tonight among luminaries in the fight against pediatric brain tumors. They are the very people you support—innovators like Bernadine R. Donahue, MD, whose work in radiology has given a whole generation a chance to survive—something impossible to imagine before her. You stand beside philanthropists like Viscogliosi Brothers, LLC, founded by three men dedicated to funding the most promising medical technology advancements and giving as much as they can to speed forth the cure. They know, as you do, that funding is the key. Leading the charge tonight is our Mistress of Ceremonies, Ms. Arielle Jacobs. Her magnificent debut solo album is titled “A Leap in the Dark,” appropriate as it is exactly what CBTF’s founders did bringing light where none thought they could. Her compassion and energy illuminating the

stage, she will inspire what we know will be our most successful Dream & Promise Awards Benefit ever. How do we know this? Because you are here. You who felt the same desperate need we did to save children from pain and death and families from inconceivable suffering. You who came tonight to stand with Children’s Brian Tumor Foundation and fight for futures you will not let be cut short. Thank you for giving us all this opportunity. We will make the most of it. Joseph Chan General Counsel Viscogliosi Brothers, LLC Stephen Downey Group Senior Vice President, Supply Chain Operations Vizient, Inc. Sravan K. Emany Senior Vice President, Strategy, Treasury and Investor Relations Integra LifeSciences Corporation Stuart M. Essig, PhD Chairman, Board of Directors Integra LifeSciences Corporation Robert Millham Senior Vice President, Oncology Clinical Development Services Syneos Health Dan Reuvers Corporate Vice President & President, Codman Specialty Surgical Integra LifeSciences Corporation Joseph P. Riccardo, Jr. Managing Director Guggenheim Securities Craig M. Robertson Managing Director, Life Sciences Northeast Regional Lead Accenture Steven Scebelo Vice President, Licensing & Business Development NFL Players Association President REP Worldwide Anthony G. Viscogliosi Principal Viscogliosi Brothers, LLC Dream & Promise Awards Benefit 2019 | 5

Special Guest Arielle Jacobs

Mistress of Ceremonies

Bank of America Merrill Lynch is proud to support CBTF’s 17th Annual Dream & Promise Awards Benefit. Congratulations to Bernadine R. Donahue, MD & Viscogliosi Bros., LLC on your well-deserved recognition. bofaml.com

Currently starring as Princess Jasmine in the smash-hit Broadway musical, Disney’s Aladdin, Arielle Jacobs is a California native whose journey from small farm town to The Great White Way is a tale of perseverance, moxie and true talent. Known for her “songbird-like ability,” Ms. Jacobs made her Broadway debut starring opposite Lin-Manuel Miranda in the final Broadway cast of his four-time Tony and Grammy award-winning musical In The Heights. Praised as “compelling” and “radiant” by Variety Magazine, and her voice as “powerful” by The New York Times, Ms. Jacobs continued her meteoric rise wowing audiences with starring roles in Wicked on Broadway, Rent, Disney’s High School Musical, and Into the Woods where she performed opposite Emmy-nominated actor Tituss Burgess. She has starred in two world-premiere plays by Pulitzer-winning playwright and director Nilo Cruz, Sotto Voce and Farhad or The Secret of Being, and has worked with Tony-winners David Hyde Pierce, Christopher Gattelli and Richard Maltby, Jr., and Drama Desk-winner Ed Iskander, her limitless talent always in demand.

thrilled by her singing of the National Anthem for the Boston Celtics, the Texas Rangers and twice for the L.A. Kings. No stranger to charity, Ms. Jacobs is the founder of The Girls Camaraderie Project, an organization working to build camaraderie and community instead of competition among middle-school girls. She has produced numerous benefit concerts to raise awareness and funds for her organization in New York and Los Angeles, as well as a benefit concert for Broadway Cares/Equity Fights AIDS with the touring cast of In the Heights. Her compassion and readiness to get the job done makes her an ideal match for Children’s Brian Tumor Foundation. Ms. Jacobs soaring debut solo album, “A Leap In the Dark: Live at Feinstein’s/ 54 Below,” is an autobiographical journey highlighting some of her struggles and feats. Ms. Jacobs brings with her a firm belief in the ability to triumph over adversity and a personal mission to keep positivity central in the lives of children, all of which she most graciously and powerfully offers us tonight.

Ms. Jacobs has performed onstage in many of America’s greatest concert halls, including Lincoln Center and The Kennedy Center, and beside legendary artists such as Wynton Marsalis and the Jazz, Chaka Khan, Teena Marie, and Stephen Schwartz. Sports fans have been “Bank of America Merrill Lynch” is the marketing name for the global banking and global markets businesses of Bank of America Corporation, including Bank of America, N.A., Member FDIC. ©2019 Bank of America Corporation. GBAM-103AD ARK9HFYFARK9HFYF Dream & Promise Awards Benefit 2019 | 7

Pioneer Award for Radiation Oncology Bernadine R. Donahue, MD Children’s Brain Tumor Foundation is proud to honor Bernadine R. Donahue, MD, with the Pioneer Award for Radiation Oncology. Combining research with a patient-first approach, Dr. Donahue has dedicated her career to ever-evolving patient care for minimal negative impact and maximum success. Educator, physician, and scientist, Dr. Donahue’s work contributes to a larger team effort to improve the lives of children with cancer and bring hope to some very challenging situations.

Wwe’re on a mission

–to heartwarm our families, our schools, and our communities. In an era where face-to-face conversations and contact are declining, building connections, resilience and empathy can make all the difference for kids’ well-being. We are partnering with leading organizations to help kids, parents and teachers build more meaningful connections and create a more inclusive and empathetic community. Visit heartwarmingproject.com to learn more.

| For more information visit thehersheycompany.com

8 | Dream & Promise Awards Benefit 2019

Born in New York, Dr. Donahue attended the Bronx High School of Science and received her BA/MD from Boston University’s six-year medical program. She followed this with an Internal Medicine internship and residency at Boston University Medical Center. During her residency, Dr. Donahue spent a great deal of time with her patients in the Radiation Oncology area, encouraging them through treatment and even transporting them back and forth. This hands-on, full-care approach would inspire the trajectory of Dr. Donahue’s career and define the patient-first philosophy essential to her work. Excited by the advancements happening in oncology, Dr. Donahue returned to New York where she was a Radiation Oncology resident, and then Chief Resident at NYU Medical Center. At NYU, she became involved in the Radiation Therapy Oncology Group and the Children’s Oncology Group, NCI-designated national cooperative groups running trials to study patients with brain tumors and pediatric tumors, in the process discovering one of the central focuses of her career. In 2005, Dr. Donahue became Attending Physician at Maimonides Medical Center and Clinical Director of Radiation Oncology at Maimonides Cancer Center. Seven years later, she was named Vice-Chairman of Radiation Oncology.

Among the many committees Dr. Donahue has served and continues to serve on, nothing could be more natural than Dr. Donahue’s position as Co-Director for the Committee of Mutual Respect at MMC. Her philosophy from the start, she treats patients holistically, watching out for them socially as well as medically, and recognizing, as she says, “that it must be an overwhelming experience to just even walk into the building.” Her respect for the dignity of her patients is the north star she has followed through every step of her impactful career. Throughout, Dr. Donahue has maintained regular presence in the classroom, further testimony to her dedication as stalwart fighter for patient well-being, training new generations to work with the same enthusiasm and compassion as she does. Clinical Associate Professor of Radiation Oncology at NYU School of Medicine and author of over 50 publications plus book chapters, abstracts and editorials, Dr. Donahue is both blazing trails and leading others up them. Technological expert and developer, fierce researcher, consummate educator, and patient advocate, Bernadine R. Donahue, MD, is truly a pioneer.

Dream & Promise Awards Benefit 2019 | 9

Dream & Promise Award Viscogliosi Brothers, LLC Our Dream & Promise Award recipient, Viscogliosi Brothers, LLC, is an organization founded on a promise to foster life-saving innovations in the medical field through studious research and bountiful investment in the latest and best technologies and treatments. Founded by brothers Anthony, John and Marc Viscogliosi, their philosophy of “More…Better…First!” powers their success and their whole-hearted approach to philanthropy. Longtime friends of Children’s Brain Tumor Foundation, their contributions have been critical in the fight against pediatric brain and spinal cord tumors. Founded in 1999, Viscogliosi Brothers, LLC, specializes in venture capital, private equity and merchant banking for the neuromusculoskeletal industry. Creating, building, operating and financing companies focused on surgeon development innovation to address unmet clinical needs, their work brings about lifechanging technologies. Knowing funding is the key to innovation, Viscogliosi Brothers’ work has allowed countless patients to take back their lives. One of the first orthopedic industry analysts, Anthony G. Viscogliosi, a Principal at Viscogliosi Bros., LLC and the Executive Chairman and CEO of MCRA has authored well over 6,500 pages of investment research for more than 900 research reports. An accomplished chief executive, entrepreneur and business strategist leading businesses across all phases of development, he has founded more than 20 companies and investment funds in the neuromusculoskeletal industry and serves or served as chairman, executive chairman, CEO, president, managing director or managing member of more than 15 businesses. Anthony was previously founder, Chairman and Chief Executive Officer of Spine Solutions, Inc. and Small Bone Innovations, Inc. and co-founder of Ascent Healthcare Solutions, Inc., Centinel Spine, LLC, Knee Creations, LLC, MCRA, LLC, Paradigm Spine, LLC, and Woven Orthopedic Technologies, LLC. Since 2009, Anthony has served multiple times as Dream & Promise Awards Benefit Co-chair. He has a B.A. in Economics from the University of Michigan – Dearborn campus as well as an honorary doctorate of humane letters from New York College of Podiatric Medicine, and a graduate of the U.S. Navy Supply Corps School. 10 | Dream & Promise Awards Benefit 2019

With more than 20 years operations and turn-around experience in the orthopedic industry, John J. Viscogliosi is the Chairman and Chief Executive Officer of Centinel Spine. Passionate about operational excellence, product innovation and cultural transformations, John previously co-founded Paradigm Spine, LLC, Small Bone Innovations, Inc, MCRA, LLC, as well as Knee Creations, LLC and Spine Solutions, LLC, where he was also on the Boards. He served as Vice President of Investments at Stifel, Nicolaus & Co. and as an Associate Director of Investments at Rodman & Renshaw. He is a graduate of Wayne State University with a B.S. in Criminal Justice. John has served several times as Co-Chair for the Dream & Promise Awards Benefit. Expert in clinical and regulatory strategies, intellectual property development, and strategic commercial access market opportunities, Marc R. Viscogliosi is a founder of Paradigm Spine, LLC, and Chairman of the Board of Managers and Chief Executive Officer since August 2004. He was co-founder and Secretary of the Board of Directors of Spine Solutions, Inc., acquired by Synthes-Stratec in 2003, and co-founder and Chairman of Knee Creations, LLC, acquired by Zimmer in 2013. Prior to co-founding Viscogliosi Brothers, LLC, Marc spent six years researching and banking musculoskeletal companies. He is a graduate of New York University with a B.A. in Economics and Political Science. Together and separately, the Viscogliosi brothers have made philanthropy a way of life, using both their company and personal assets to bring about solutions for those in the grip of debilitating and fatal illnesses. Always ready to help and expert at raising the funding necessary to move care forward, Viscogliosi Brothers, LLC, is the product of charity and action, constant companions to Children’s Brain Tumor Foundation on the road to the cure for pediatric brain and spinal cord tumors. Dream & Promise Awards Benefit 2019 | 11

Benefit Co-Chair Congratulations to our honorees Bernadine R. Donahue, MD and Viscogliosi Brothers, LLC and its founders, Anthony, John and Marc. Special recognition to Stacia Wagner for 14 years of dedication to our CBTF children and families, for incredible advocacy and work on their behalf. Congratulations on your new role as Co-President!

My infinite thanks to the entire amazing CBTF staff and to my fellow CBTF Boardmembers.

Joseph Chan

General Counsel Viscogliosi Brothers, LLC

The Childrenâ&#x20AC;&#x2122;s Brain Tumor Foundation welcomes back Joseph Chan as one of the eveningâ&#x20AC;&#x2122;s dedicated co-chairs. Mr. Chan is the General Counsel of Viscogliosi Brothers, LLC and its portfolio companies. Mr. Chan has more than 25 years of legal experience, including over 17 years in a senior role in medical device and orthopedic companies and over 8 years as a senior attorney in national law firms. Prior to Viscogliosi Brothers, Mr. Chan was a Senior Counsel at Becton, Dickinson & Company. Mr. Chan has significant experience in mergers and acquisitions, divestitures, equity and debt offerings, strategic alliances, intellectual property, litigation, governmental investigations, employment, compliance and clinical and regulatory matters.

Lionel Leventhal & Royalty/Revenue Interest Capital

12 | Dream & Promise Awards Benefit 2017

Dream & Promise Awards Benefit 2019 | 13

you. you.

Benefit Co-Chair

you. you. you.

Stephen Downey

you.

Group Senior Vice President Chain Operations Vizient, Inc.

y o Supply u. you. you. you. you. you.

y oThe u . Children’s Brain Tumor Foundation is

B:9.5"

T:9"

pleased to welcome back Stephen Downey y oto u . the 17th annual Dream & Promise Awards Benefit. Steve serves as Group Senior Vice you. President of supply chain operations at Vizient, Inc., the largest member-driven you. health care performance improvement company in the country. Vizient’s diverse you. membership base includes academic centers, pediatric facilities, y omedical u. community hospitals, integrated health networks and non-acute health y odelivery u. care providers and represents more than y o$100 u. billion in annual purchasing volume. Vizient’s headquarters are in Irving, Texas.

S:8.5"

Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank k you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you.

you.

In his role, Steve leads the team that

members’ evolving supply chain y osolves u.

operational needs. The role includes responsibility, strategic direction, y ofinancial u. operational execution, and relationship across the national y omanagement u. member base. you. you.

Steve joined Vizient from GEODIS, an international supply chain transport and logistics firm operating in 67 countries around the globe. He served as senior vice president of the healthcare and consumer electronics vertical, where he led strategy and commercial activities. Prior to that, he worked nine years in increasing roles of responsibility at Integra Life Sciences, a medical technology firm offering innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Earlier, he worked at Scott Medical Products for 11 years in various commercial and operational leadership roles. Steve graduated from Lehigh University in Bethlehem, Pa., with a bachelor’s degree in electrical engineering and a master’s degree in management of technology. Steve and his wife have 8-year-old twin boys. In addition to his role as co-chair of the Foundation’s Dream & Promise Awards Benefit, he is a board member of Friends Health Connection.

you. you. you.

For your work empowering the ideas of young dreamers,

WE CAN NEVER THANK YOU ENOUGH.

14 | Dream & Promise Awards Benefit 2019

Dream & Promise Awards Benefit 2019 | 15

Benefit Co-Chair Sravan K. Emany

Senior Vice President Strategy, Treasury & Investor Relations Integra LifeSciences Corporation

We Deliver Broader and Deeper Solutions Experience the breadth and depth of our tissue regeneration technology and specialized extremity solutions

Integra LifeSciences’ Orthopedics and Tissue Technologies division is delighted to be a continued supporter of the Children’s Brain Tumor Foundation’s 31-year commitment to help find a cure for childhood brain tumors . To date, the Children’s Brain Tumor Foundation (CBTF) has provided research grants totaling $10.5 million to leading doctors and researchers at top institutions throughout the United States.

The Children’s Brain Tumor Foundation is proud to welcome back Sravan K. Emany as one of the evening’s dedicated co-chairs. As Senior Vice President, Strategy, Treasury and Investor Relations, Sravan is responsible for identifying and driving growth and value creation initiatives on a global basis. In addition to leading those strategic initiatives, he is responsible for developing financing strategies for the company. Also, Mr. Emany manages and communicates information to the financial community and its shareholders as it pertains to operations and financial standing. Mr. Emany has spent 18 years in mergers, acquisitions and investment banking in leadership roles with major global firms, including Bank of America Merrill Lynch, Goldman Sachs and Morgan Stanley. Prior to joining Integra in 2018, Mr. Emany was a Managing Director in the Mergers & Acquisitions group at Bank of America Merrill Lynch. While there, he led numerous mergers and acquisitions in the healthcare sector, including the recent Integra acquisitions of Codman Neurosurgery and Derma Sciences. Mr. Emany holds a B.A. in international relations from The Johns Hopkins University and an M.A. in international relations and international economics from The Johns Hopkins School of Advanced International Studies (SAIS).

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation or its subsidiaries in the United States and/or other countries. ©2019 Integra LifeSciences Corporation. All rights reserved.

16 | Dream & Promise Awards Benefit 2019

integralife.com Dream & Promise Awards Benefit 2019 | 17

Benefit Co-Chair Stuart M. Essig, PhD

Chairman, Board of Directors Integra LifeSciences Corporation The Children’s Brain Tumor Foundation is honored to welcome back Stuart M. Essig, PhD, as co-chair for the 17th annual Dream & Promise Awards Benefit. Stuart currently serves as managing director of his family office, Prettybrook Partners LLC, investing in medical technology companies. Prettybrook has approximately 20 active investments in a variety of companies, typically as a co-investor with institutional private equity.

CRE AT ING VALUE IN HE ALT HC ARE AND T HE L IF E S C IENCE S Proud supporters of the Children’s Brain Tumor Foundation’s continued dedication and resultant discoveries that hold the promise of improving the lives of affected children today, and discovering the means of prevention for future generations.

512 West MLK Jr. Blvd., #320 | Austin, TX 78701 Erin S. Enright, Managing Partner | Stuart M. Essig, PhD, Managing Partner 18 | Dream & Promise Awards Benefit 2017 2019

Dr. Essig has been Integra LifeSciences Corporation’s (NASDAQ:IART) Chairman of the Board of Directors since 2012 and a Director since he joined Integra in 1997. He served as the company’s Chief Executive Officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 20-year tenure with the company, Integra has grown revenues from approximately $15 million to over $1.4 billion and its market capitalization from approximately $100 million to an aggregate valuation of more than $5.0 billion. Share price during his tenure has increased from approximately $6 to over $100 on a splitadjusted basis. Before joining Integra, Dr. Essig was Managing Director of the medical technology practice at Goldman, Sachs & Co. He had ten years of broad healthcare experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. Dr. Essig has chaired audit, compensation and nominating and governance committees, served as lead director, and participated in CEO succession processes, on the boards of numerous public companies, ranging in size from several hundred million dollars to $30 billion in levered market capitalization. In addition to Integra, Dr. Essig currently serves on the Board of Directors of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Owens & Minor, Inc. (NYSE:OMI) and SeaSpine Holdings Corporation (NASDAQ:SPNE). He is also the Chairman of the Board of Directors of private-equity backed Breg, Inc., a premium provider of high-value sports medicine products and services that advance patient care in orthopedics.

He is an executive-in-residence at Cardinal Partners and a venture partner at Wellington Partners Advisory AG, both venture capital firms. He also serves as a senior advisor to TowerBrook Capital Partners and Water Street Healthcare Partners. Dr. Essig is a founding investor member of Tigerlabs, a Princeton-based business accelerator. He previously served on the Board of Directors of St. Jude Medical Corporation (NYSE:SJM) from 1999 to 2017, prior to its sale to Abbott Corporation. From 2005 until 2008 he served on the Board of Directors of Zimmer Holdings, Inc. (NYSE:ZMH), and from 1998 to 2002, he served on the Board of Directors of Vital Signs, Inc. (NASDAQ:VITL). He also served on the executive committee, nominating and governance committee, and as treasurer of ADVAMED, the Advanced Medical Technology Association. Dr. Essig is also involved in several non-profit charitable organizations, including from time to time serving on their boards. From 2012 to 2018, he served on the Board of Directors of Trentonarea non-profit, Isles, Inc. and since 2006 has served as a volunteer and fund raiser for the Children’s Brain Tumor Foundation. He serves on the Leadership Counsel of the Princeton University School of Engineering and Applied Sciences, and the NACD Compensation Committee Chair Advisory Counsel. Dr. Essig received an A.B. degree, and graduated with magna cum laude and Phi Beta Kappa honors from the Woodrow Wilson School of Public and International Affairs at Princeton University. He completed his M.B.A. and Ph.D. degrees in financial economics from the University of Chicago, Graduate School of Business. Dr. Essig, his wife and their four children can often be found in Austin, TX. Dream & Promise Awards Benefit 2019 | 19

Benefit Co-Chair Robert Millham

Senior Vice President Oncology Clinical Development Services Syneos Health

The Children’s Brain Tumor Foundation welcomes back Robert Millham as one of the evening’s dedicated co-chairs. Bob is Senior Vice President, heading Oncology Clinical Development Services at Syneos Health. He has 20 years of pharmaceutical industry experience, in roles including laboratory, clinical development and clinical operations. His most recent role was as Chief Operating Officer at Odonate Therapeutics. At Odonate, he was responsible for growing their clinical development organization which implemented a global phase 3 trial for the evaluation of tesetaxel in Metastatic Breast Cancer (CONTESSA). From 2015 to 2017, Bob was Senior Vice President and General Manager, Hematology & Oncology at inVentiv Health. Prior to joining inVentiv, he was Vice President, Oncology Clinical Operations, in Pfizer Worldwide Research & Development. He joined Pfizer Oncology in 2004, and served in roles including Translational Medicine Lead, Clinical Lead, and Medical Team Lead before assuming his role in Development Operations in 2013. Prior to joining Pfizer, he worked for companies in Biotech and Agri-Biotech. He is an author or co-author on multiple peer-reviewed publications, abstracts and presentations. Bob holds degrees in Biology (Middlebury College), Microbiology (University of New Hampshire) and Pharmaceutical Medicine (Hibernia College). He works from his home office in Guilford, CT.

Bob and Michele Millham are proud to continue to support the Children’s Brain Tumor Foundation Dream & Promise Awards Benefit 2019 | 21

Benefit Co-Chair Dan Reuvers

Corporate Vice President & President, Codman Specialty Surgical Integra LifeSciences Corporation

The Children’s Brain Tumor Foundation is proud to welcome back Dan Reuvers as co-chair for the 17th annual Dream & Promise Awards Benefit. Mr. Reuvers is Corporate Vice President and President of Codman Specialty Surgical. The Codman Specialty Surgical division is a market leader in providing neurosurgical and other surgical solutions, including Integra’s CUSA® tissue ablation system, Mayfield®cranial stabilization system, DuraGen® and DuraSeal® dural repair products HAKIM® & CERTASä Plus programmable valves and many other lifesaving surgical instruments and products.

Integra LifeSciences’ Codman Specialty Surgical division is committed to advancing surgical innovations that make a difference in patient care. Tonight, we honor the Children’s Brain Tumor Foundation and its long-standing dedication to bringing research, education and caring support to patients and families affected by pediatric brain or spinal cord tumors.

Mr. Reuvers has more than 30 years of experience in the medical technology field and held various executive level positions in sales, marketing and general management. Prior to being named President of the Codman division at Integra, Mr. Reuvers led the significant growth of its overall international businesses in Europe, Middle East, Africa, Latin America, Asia Pacific and Canada. Previous to this role, he also held various leadership positions, including Vice President of Marketing and Product Development, President of the acute surgical business, and President of the instruments franchise. Before joining Integra, he was President of Omni-Tract Surgical until it was acquired by Integra in 2008 and President of Advanced Respiratory, Inc., before leading its sale to Hill-Rom.

22 | Dream & Promise Awards Benefit 2019

integralife.com Dream & Promise Awards Benefit 2019 | 23

The Bebe Foundation is proud to support the critical work of the Children’s Brain Tumor Foundation

We salute this evening’s honorees and the Foundation for all of their noteworthy achievements.

Benefit Co-Chair Joseph P. Riccardo, Jr. Managing Director Guggenheim Partners

The Children’s Brain Tumor Foundation is most pleased to welcome back Joseph P. Riccardo, Jr. as co-chair for the 17th annual Dream & Promise Awards Benefit. Mr. Riccardo is a Managing Director, Equity Sales at Guggenheim Partners. Mr. Riccardo has more than 24 years of Wall Street experience. His clients include several large hedge funds, global mutual funds, and family offices. Prior to joining Guggenheim in August of 2018, he was a co-Syndicate Manager at Westport Capital Markets (WCM), and a Managing Director in Institutional Equity Sales at Evercore ISI. Mr. Riccardo has also held senior sales positions at Citibank, Bank of America, FTN Equity Capital, Ladenburg Thalmann, and Cantor Fitzgerald. During his institutional sales tenure, Mr. Riccardo’s strongest area of expertise is healthcare—a passion that is in his family, as he followed his father’s more than 30-year career as a prominent pharmaceuticals analyst. Mr. Riccardo holds a Bachelor’s degree in Economics from the University of North Carolina at Chapel Hill, where he was a member of the Sigma Phi Epsilon Social Fraternity, a JV Manager and Varsity statistician for the men’s basketball team, and a co-head of the UNC Undergraduate Peer Tutoring program.

Dream & Promise Awards Benefit 2019 | 25

Benefit Co-Chair Craig M. Robertson Managing Director Life Sciences Northeast Regional Lead Accenture

SHAPE THE FUTURE Accenture is proud to support the 17th Annual Dream & Promise Awards Benefit and celebrate tonight’s honorees. We applaud the Children’s Brain Tumor Foundation for all of their incredible achievements.

The Children’s Brain Tumor Foundation welcomes Craig M. Robertson as one of the evening’s dedicated co-chairs. Over the past 23 years Craig has supported pharmaceutical and biotechnology clients to help bring life-saving therapies—including novel pediatric cell and gene therapy initiatives—to market. Beyond supporting the introduction of new therapies, Craig has worked with senior executives on new ways to engage with healthcare ecosystem partners to provide patient services capabilities, helping providers and patients to deliver the most impact. In his current role, Managing Director in Accenture’s Life Sciences Practice, Craig is responsible for overseeing Accenture’s Life Sciences Practice in the Northeast region of the United States. He sponsors Accenture’s annual Health Tech Challenge, bringing together pharmaceutical companies, payers, providers and start-up companies from around the world to explore new ways to improve patient health. Craig also currently serves on the Leadership Committee for Community Hope, a non-profit organization dedicated to helping veterans and their families overcome mental illness, addiction, homelessness and poverty. Previously, Craig led Accenture’s Global Life Sciences Marketing & Sales Consulting Practice, which included a portfolio of Life Sciences clients headquartered in Europe. Craig holds a BA in Marketing from Denison University and an Executive MBA from Cornell.

Dream & Promise Awards Benefit 2019 | 27

Providing compassion, hope, healing The CBTF is dedicated to improving the treatment, quality of life, and the longterm outlook for children with brain and spinal cord tumors. We are proud to support their efforts. www.pwc.com

Benefit Co-Chair Steven Scebelo

Vice President, Licensing and Business Development NFL Players Inc. President REP Worldwide

The Children’s Brain Tumor Foundation welcomes Steven Scebelo as one of the evening’s co-chairs. Steven serves as Vice President, Licensing and Business Development for NFL Players Inc., the licensing and marketing subsidiary of the NFL Players Association, which has been named LIMA’s Best Sports Licensing Program on multiple occasions. NFL Players Inc. is the exclusive source to connect partners and their customers directly with all active NFL players, and provides clients with B2B solutions including group player licensing rights, marketing strategy and player engagement. Under his guidance, NFL Players Inc. has become a groundbreaker in helping NFL players and other athlete groups grow their revenue objectives through marketing and licensing. In his role, Steven oversees business development, licensing and marketing operations, which includes leading a team responsible for representing the intellectual property for a group of more than 2,000 current NFL players, plus a roster of more than 70 digital, apparel, and hardlines licensees responsible for $1.6B in retail sales. The NFL Players Association is currently ranked by License Global as the 34th largest licensing program worldwide. Steven also serves as the president of newly-formed REP Worldwide, the first-ofits-kind group player representation business that provides licensing and brand management services to athlete-driven sports properties. Founding partners include the U.S. Women’s National Team Players Association and Women’s National

Basketball Players Association. Built on the foundation of more than 25 years of continued revenue growth at NFL Players Inc. that supplements athletes’ on-field earnings, REP Worldwide thus far has executed licensing agreements with over 25 companies across categories that promote players of the U.S. Women’s National Soccer Team, the WNBA and USA Rugby including licensed t-shirts, socks, scarves, novelties, customized jerseys, promotional products and digital collectibles. Over his career, Steven has increased domestic and international merchandise licensing revenues for world-class brands in the sports, consumer products, and media industries, including directing the $500 million North American retail licensing program for The Coca-Cola Company and extensive work in sports licensing via management positions at the NBA, the 1996 Olympic Games, and Major League Baseball. Prior to joining NFL Players Inc., Steven was principal in TM317, a boutique licensing and merchandising agency that served a roster of sports and entertainment properties. He also spent several years as senior vice president of cross-platform marketing at Gemstar-TV Guide, where he led integrated marketing efforts and oversaw consumer engagement and social media initiatives. As senior vice president of merchandise licensing, he grew the TV Guide program from a start-up to a $50 million endeavor for which TV Guide was nominated as LIMA’s Best Corporate Brand License of the Year. Dream & Promise Awards Benefit 2019 | 29

Benefit Co-Chair

Making a difference for the little ones.

Anthony G. Viscogliosi Principal Viscogliosi Brothers, LLC

The men and women of Lockheed Martin are honored to sponsor the Children’s Brain Tumor Foundation.

VC19-10573

Learn more at lockheedmartin.com

The Children’s Brain Tumor Foundation is delighted to welcome back Anthony G. Viscogliosi as co-chair for the 17th annual Dream & Promise Awards Benefit. Anthony and his brothers, John and Marc, are honored tonight with the Dream & Promise Award, recognizing their leadership. Mr. Viscogliosi has healthcare experience as an entrepreneur, executive, and financier and is the co-founder of Viscogliosi Brothers, LLC, a merchant bank and venture capital firm focused on the musculoskeletal industry. With an innate ability to predict market trends and develop innovative solutions for unmet clinical needs, Mr. Viscogliosi has founded more than 20 companies and is responsible for transforming 5 practices including medical device reprocessing, spine arthroplasty, nucleus arthroplasty, knee-pain treatment, and total ankle arthroplasty. From an investor perspective, Mr. Viscogliosi was the first orthopedic industry analyst on Wall Street and executed more than 170 orthopedic deals with partners such as Johnson & Johnson, Stryker Corporation, Zimmer Holdings, and Abbott, among others. Past exits have generated in excess of $2.1 billion in capital returned. Mr. Viscogliosi received a BS in Economics from the University of Michigan and an Honorary PhD from New York College of Podiatric Medicine. Mr. Viscogliosi is a retired Lieutenant Commander of the United States Navy Reserve.

30 | Dream & Promise Awards Benefit 2019

Dream & Promise Awards Benefit 2019 | 31

Dr. John W. & Jeanne M. Hubbard congratulate the Childrenâ&#x20AC;&#x2122;s Brain Tumor Foundation

and are proud to support the 17th Annual Dream & Promise Awards Benefit

Dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer

www.odonate.com O UR

VA LUE S

F O C U S O N T H E PAT I E N T We are dedicated to improving the lives of patients in need O P E R AT E W I T H I N T E G R I T Y Our word is our most valuable asset B R I N G PA S S I O N We take pride in our work and strive for excellence in all that we do B E C R E AT I V E The best way is often yet to be discovered BE KIND We believe in the inherent goodness of people and strive to treat everyone with kindness FOSTER UNITY We are one community PROMOTE EQUAL OPPORTUNITY Every person should be offered an opportunity to achieve success in all aspects of life GIVE FORWARD We receive happiness from helping those in need within our local and global community FIND JOY We support personal goals for physical, mental and spiritual well-being

Childhood Brain and Spinal Cord Tumor Fact Sheet Brain and spinal cord tumors remain the deadliest childhood cancer, despite decreases in overall cancer death rates since the early 1990s. Nearly 5,000 brain and spinal cord tumors are diagnosed each year in children and teens. • Roughly one-third of children diagnosed with a brain tumor will not survive beyond five years. • Brain tumors are often difficult to diagnose because their signs and symptoms may mimic those of other disorders. Symptoms may appear in an emergency situation followed by surgery within 24 hours.

There are over 28,000 brain tumor survivors alive today in the United States. Survivorship is a relatively new phenomenon, and many survivors are just reaching adulthood now. • Surviving a brain tumor doesn’t mean the child is “home free.” In fact, brain tumor survivors often face not only on-going medical challenges, but physical, cognitive and emotional changes. • Young adult survivors are five times more likely to be unemployed than other childhood cancer survivors.

• Survivors often describe life after a brain tumor as lonely and frequently experience bullying because of their • Depending on the tumor type, rate of differences. growth and location of tumors, treatment may include any combination of surgery, • The brain tumor diagnosis impacts the radiation, and chemotherapy. Treatment entire family. Families now must learn to of brain or spinal cord tumors usually live with a new “normal” and adjust their begins with surgical resection to remove dreams and expectations. all or part of the tumor. Although complete removal of the tumor (gross Research progress has been total resection) is often the treatment of challenging for several reasons: choice, partial removal of the tumor will occasionally relieve a child’s symptoms. • There are many different types of Surgery also establishes the diagnosis by childhood brain and spinal cord tumors. obtaining portions of the tumor for a • Because the disease is rare and tissue pathologist’s analysis. samples of tumors are small, it takes • Even non-malignant tumors (slowtime to test and validate new treatment growing and not spreading) can be options. dangerous in the brain because of their • Because this is considered a rare location and because they destroy disease, funding is often not available for healthy cells that may be vital to the on-going research or clinical trials. quality of life or life itself. • Doctors and researchers are dealing with • Children with brain tumors often spend a growing child’s brain and body, so they long periods of time in the hospital, must first ensure they avoid harming the oftentimes with their parents staying child during surgery or any other full-time, too. They are isolated from treatment procedures. their peers and lose the experience of normal childhood.

Dream & Promise Awards Benefit 2019 | 35

About the Children’s Brain Tumor Foundation Please visit our website at www.cbtf.org.

Gary Brewster and Houlihan Lokey are proud to support the

Children’s Brain Tumor Foundation

CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING

HL.com 36 | Dream & Promise Awards Benefit 2019

RESEARCH AND TRAINING The Children’s Brain Tumor Foundation (CBTF) is committed to finding a cure for childhood brain tumors. During its 31-year history, CBTF has awarded over 75 research grants totaling $10.5 million to leading doctors and researchers at top institutions throughout the United States. This funding underwrites research into the causes of, and effective treatments for, childhood brain and spinal cord tumors. CBTF has also provided over $650,000 for professional training and clinical fellowships in the field of pediatric neuro-oncology with a goal to increase the number of experienced professionals equipped with state of the art information and specific knowledge in the field of pediatric brain and spinal cord tumors.

families regardless of income, CBTF offers all programs and information free of charge. Through its 31-year history, CBTF has touched over 50,000 individuals with direct support, information and/or other services.

CBTF offers a wealth of information and resources through its newly redesigned website, www.cbtf.org, featuring up-to-date information and resources. We also continue to offer valuable print materials. Our family resource guide, Finding Your Way, now in its 6th edition, was created by parents and professionals as a comprehensive guide to childhood brain tumors. The guide covers diagnosis information in lay language and information about short- and long-term physical, medical, emotional and educational effects. It offers the most up-to-date resources and information on complementary medicine THE CHILDREN’S BRAIN TUMOR and nutrition and covers the lifelong impact TISSUE CONSORTIUM on all family members, including a new This year, CBTF continues its significant chapter for siblings. The guide, in English funding of the Children’s Brain Tumor Tissue and Spanish, is available on the CBTF Consortium (CBTTC). Our philanthropic website and is distributed in hard copy free partner in this effort is Licensing of charge to families, professionals, and International (formerly LIMA), to whom we pediatric medical centers worldwide. are deeply grateful. Since 2004, Licensing International has donated almost $6.5 CBTF’s children’s book, Parker’s Brain million to CBTF, restricting those funds first Storm, created to assist children in for the creation and support of the CBTTC understanding brain surgery, follows Parker, and second for critical research into brain a young bear, through his brain tumor tumor cures and treatments. journey, including MRI scans and surgery. The story helps eliminate the daily fears What started out as a hypothetical faced by children when they are diagnosed question—“What would happen if we were with a brain tumor. able to get researchers from multiple institutions to collaborate and actually work SOCIAL MEDIA together to find a cure?”—has become the Through Facebook, Twitter and Instagram largest brain tumor biorepository on earth. CBTF shares research updates, stories With an operations center located at the of families and survivor accomplishments, Children’s Hospital of Philadelphia, the and information about our partners. CBTTC now includes 16 member institutions Each month, CBTF distributes an Events across the country and around the globe and Activities newsletter and Career (including Australia, China, and Italy). Profile newsletter to over 7,000 families and professionals. FAMILY SUPPORT SERVICES CBTF is the national leader in providing FAMILY-2-FAMILY quality of life programs to families with Our signature program, the Family-2-Family children affected by a brain or spinal cord (F2F) Mentor Program, connects caregiver, tumor. We also conduct our own quality of survivor, and bereaved caregiver mentors to life research, which helps in creating families who are seeking peer support both evidenced-based programs and supporting through on-line chats and in person. brain tumor survivors beyond the medical (continued on next page) aspects. In order to meet the needs of Dream & Promise Awards Benefit 2019 | 37

About the Children’s Brain Tumor Foundation (continued from previous page) This program draws on the expertise and support from people who have shared a similar experience. The F2F Network also connects bereaved parents and family members to bereaved mentors for support, this year adding a sibling mentor program. With locations in Boston, Los Angeles, Minneapolis, San Francisco, Seattle, Washington, D.C., and the NYC tri-state area, the program currently has over 500 volunteer parent, survivor, and bereaved mentors from around the country. This year, F2F programs are launching in Colorado, Illinois and Ohio.

ONLINE SUPPORT CBTF uses its online support to reach people regardless of geographic location. CBTF offers online groups for teen and young adult survivors, parents, and brain tumor survivors in college. Summer 2019 sees the addition of online support groups for the parents of younger children. RETREATS/CONFERENCES CBTF partners with Camp Mak-a-Dream in Gold Creek, MT to offer three 6-day retreats for young adult and adolescent brain tumor patients and survivors. This “Heads Up Conference” includes a combination of recreational activities, educational seminars, leadership training and building of a peer support community. Each year, 150 survivors attend the camps cost-free.

a brain tumor diagnosis, treatment and life after treatment alone. Professionals and peers are accessible daily by CBTF’s toll-free phone number (866-228-4673), through the Internet or in person to provide clinical support, information and advocacy to families.

BEREAVEMENT Pediatric brain cancer is the leading cause of cancer-related death in children. Unfortunately, roughly one-third of children diagnosed with a brain tumor do not survive past five years. CBTF offers a Loss, Grief and Bereavement Program. This program offers counseling, support groups and mentor connections, as well as educational and therapeutic materials to bereaved families. Additionally, CBTF’s monthly online grief discussions, The Grieving Experience, as well as “Surrounded by Love’s” quilting program funded by Jenna’s Rainbow Foundation, give the bereaved multiple outlets to grieve in the healthiest ways for them.

CAREER SUPPORT Childhood brain tumor survivors face a much higher unemployment rate than do other childhood cancer survivors. To address this problem, CBTF started a Career Development Program coupled with CBTF’s Young Professional Group. This program provides ongoing group and individual peer support for teen and young CBTF hosts an annual “Just Us” Conference adult brain tumor survivors in the NYC area. for fathers and their brain tumor-surviving With funding from Jenna’s Rainbow children. The conference brings 30 fathers Foundation, CBTF will be reaching out to and survivors together for a unique bonding corporations to expand employment and relationship building experience. opportunities for survivors. Fathers sometimes have difficulty discussing the emotional impact a brain ADVOCACY tumor diagnosis has on them. They rarely CBTF is a charter member of the Alliance meet with other fathers and are sometimes for Childhood Cancer, representing more unsure of how to talk to their child or than twenty patient advocacy groups and partner about their own fears and emotions. medical and scientific organizations. This weekend retreat gives fathers the opportunity to bond with other fathers and YOU MAKE A DIFFERENCE a rare chance to spend quality time with All CBTF programs are made possible their child. “Just Us” is the only father/ through individual, corporate and survivor retreat in the nation. foundation funding. We could not exist A goal of Children’s Brain Tumor Foundation is to assure that no family or individual family member has to experience

38 | Dream & Promise Awards Benefit 2019

without the generous support of our donors and volunteers.

Dream & Promise Awards Benefit 2019 | 39

Dream & Awards Benefit Co-Chairs and Committee BENEFIT CO-CHAIRS Joseph Chan General Counsel Viscogliosi Brothers, LLC Stephen Downey Group Senior Vice President, Supply Chain Operations Vizient, Inc. Sravan K. Emany Senior Vice President, Strategy, Treasury and Investor Relations Integra LifeSciences Corporation Stuart M. Essig, PhD Chairman, Board of Directors Integra LifeSciences Corporation Robert Millham Senior Vice President, Oncology Clinical Development Services Syneos Health Dan Reuvers Corporate Vice President & President, Codman Specialty Surgical Integra LifeSciences Corporation Joseph P. Riccardo, Jr. Managing Director Guggenheim Partners Craig M. Robertson Managing Director, Life Sciences Northeast Regional Lead Accenture Steven Scebelo Vice President, Licensing & Business Development NFL Players Association President, REM Worldwide Anthony G. Viscogliosi Principal Viscogliosi Brothers, LLC

BENEFIT COMMITTEE Jeffrey C. Allen, MD Professor, Pediatric Neuro-Oncology Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders Linda Angel ** Miriam R. Barry * Educational Advocate Sephardic Bikur Holim Secretary Children’s Brain Tumor Foundation Gary Brewster * Managing Director, Financial Advisory Services Houlihan Lokey Leigh Anne Brodsky* Principal L.A.B. Licensing and Branding, LLC Vice Chair Children’s Brain Tumor Foundation

Michele G. Buck President & Chief Executive Officer The Hershey Company Robert M. Budlow* Treasurer Children’s Brain Tumor Foundation William W. Compton Senior Vice President & Chief Information Officer Integra LifeSciences Corporation Christopher Coutts* President & Chief Operating Officer American Institute Tom Curran, PhD, FRS Executive Director & Chief Scientific Officer Children’s Research Institute Donald J. Hall Eminent Scholar in Pediatric Research Children’s Mercy Kansas City Professor, Department of Pediatrics, UMKC School of Medicine Professor, Department of Cancer Biology, University of Kansas School of Medicine Robert T. Davis, Jr. Corporate Vice President & President, Orthopedics & Tissue Technologies Integra LifeSciences Corporation Ira J. Dunkel, MD Attending Pediatric Oncologist Memorial Sloan Kettering Cancer Center Chair, Pediatric Brain Tumor Consortium Richard Eisner Senior Director, Global Procurement and Strategic Sourcing Integra LifeSciences Corporation Mrs. Fred J. Epstein Neil A. Feldstein, MD, FACS Associate Professor of Neurological Surgery New York Presbyterian Columbia University Irving Medical Center Director, Pediatric Neurosurgery Morgan Stanley Children’s Hospital Jonathan L. Finlay, MB, ChB, FRCP, FRCPCH Director, Neuro-Oncology Program The Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer, Division of Hematology, Oncology and BMT Nationwide Children’s Hospital Professor of Pediatrics The Ohio State University Mark Flyer, MD Vice Chairman Department of Radiology Maimonides Medical Center Sharon L. Gardner, MD Associate Professor of Pediatrics Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders

40 | Dream & Promise Awards Benefit 2019

Stewart Goldman, MD Division Head, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation Meryl Suzanne Weiss Distinguished Professor in Hematology, Oncology and Stem Cell Transplantation Ann & Robert H. Lurie Children’s Hospital of Chicago Professor of Pediatrics Northwestern University Feinberg School of Medicine Director, Center for Clinical Trials Research Co-Director, Falk Brain Tumor Center Stanley Manne Children’s Research Institute Billy Goldstein * Executive Vice President, M&A and Corporate Development Sterling Talent Solutions Vice President Children’s Brain Tumor Foundation Jeffrey P. Greenfield, MD, PhD Vice Chairman & Associate Professor, Department of Neurological Surgery Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center Co-Director Children’s Brain Tumor Project Derek R. Hanson, MD Program Head of Pediatric Neuro-Oncology Joseph M. Sanzari Children’s Hospital Hackensack University Medical Center Children’s Cancer Institute David H. Harter, MD Associate Professor of Neurosurgery Director, Division of Pediatric Neurosurgery Residency Program Director Department of Neurosurgery New York University School of Medicine Jeanne M. Hubbard Civic Volunteer John W. Hubbard, PhD, FCP Member, Board of Directors Former President & Chief Executive Officer Bioclinica Inc. Gary D. Jaworski, PhD Co-President Children’s Brain Tumor Foundation Mark W. Kieran, MD, PhD Clinical Trial Lead, Pediatrics Program Oncology Clinical Development Bristol-Myers Squibb

Lionel Leventhal * Managing Director Ladenburg Thalmann Managing Member Royalty/Revenue Interest Capital Merchant Bank Board Chair Children’s Brain Tumor Foundation David C. Lyden, MD, PhD Stavros S. Niarchos Professor Departments of Pediatrics and Developmental Biology Weill Cornell Medicine Meyer Cancer Center Anita Nirenberg, PhD, RN, FAAN* William Randolph Hearst Professor Emerita Hunter College Vice President Children’s Brain Tumor Foundation Roger J. Packer, MD Senior Vice President Center for Neuroscience and Behavioral Medicine Endowed Distinguished Professor & Director Gilbert Family Neurofibromatosis Institute Director, Brain Tumor Institute Children’s National Health System Professor of Neurology and Pediatrics The George Washington University Medical Center Peter C. Phillips, MD Hubert J.P. and Anne Faulkner Schoemaker Endowed Chair in Pediatric Neuro-Oncology Children’s Hospital of Philadelphia Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania Ian F. Pollack, MD, FACS, FAAP, FAANS Chief, Pediatric Neurosurgery Children’s Hospital of Pittsburgh Leland Albright Professor of Neurological Surgery Vice Chairman for Academic Affairs, Department of Neurological Surgery Co-Director, UPCI Brain Tumor Program Distinguished Professor of Neurosurgery University of Pittsburgh School of Medicine Scott L. Pomeroy, MD, PhD Bronson Crothers Professor of Neurology Harvard Medical School Chair, Department of Neurology Neurologist-in-Chief Boston Children’s Hospital

Michael Prados, MD Charles B. Wilson Professor Emeritus of Neurosurgery and Professor of Pediatrics (Neuro-Oncology) University of California, San Francisco Co-Project Leader, Pacific Pediatric Neuro-Oncology Consortium Adam C. Resnick, PhD Director of the Center for Data Driven Discovery in Biomedicine Scientific Chair, Children’s Brain Tumor Tissue Consortium Scientific Chair, Pediatric Neuro-Oncology Consortium Alexander B. Wheeler Endowed Chair in Neurosurgical Research The Children’s Hospital of Philadelphia Brian R. Rood, MD Medical Director, Neuro-Oncology Program Associate Professor of Pediatrics Division of Oncology Center for Cancer and Blood Disorders Children’s National Health System Joshua B. Rubin, MD, PhD Co-Founder & Co-Director of the Pediatric Neuro-Oncology Program St. Louis Children’s Hospital Co-Leader of the Solid Tumor Therapeutics Program The Alvin J. Siteman Cancer Center at Washington University Professor of Pediatrics and Neuroscience Washington University School of Medicine Stephen A. Sands, PsyD Professor of Psychology Director, Pediatric Neuropsychology Department of Psychiatry & Behavioral Sciences Department of Pediatrics Memorial Sloan Kettering Cancer Center Paula Scott ** Charles A. Sklar, MD Director, Long-Term Follow-Up Program Memorial Sloan Kettering Cancer Center Eric S. Snyder* Managing Director Merrill Lynch Wealth Management Bank of America Corporation Vice Chair Children’s Brain Tumor Foundation Mark M. Souweidane, MD, FACS, FAAP Vice Chairman & Professor, Department of Neurological Surgery Director of Pediatric Neurosurgery Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center Co-Director Children’s Brain Tumor Project

Evan G. Stein, MD, PhD Clinical Associate Professor of Radiology and Neurology SUNY Downstate School of Medicine Vice Chairman, Radiology Education Director of Neuroradiology Maimonides Medical Center Timothy W. Vogel, MD Pediatric Neurosurgeon North Jersey Brain and Spine Center Hackensack University Medical Center Linda Wachtel, LMSW* Stacia Wagner, MSW Co-President Children’s Brain Tumor Foundation Christopher A. Walsh, MD, PhD Chief, Division of Genetics & Genomics Boston Children’s Hospital Bullard Professor of Pediatrics and Neurology Harvard Medical School Susan L. Weiner, PhD ** Founder and President The Children’s Cause for Cancer Advocacy Vice Admiral (Ret) Anthony L. Winns Deputy, Lockheed Martin International Chief Executive, Africa & Latin America Lockheed Martin Corporation Deborah F. Wisoff Jeffrey H. Wisoff, MD Professor, Department of Neurosurgery Professor, Department of Pediatrics Division of Pediatric Neurosurgery Hassenfeld Children’s Hospital at NYU Langone Health Akiva Zablocki* President Hyper IgM Foundation David Zagzag, MD, PhD Professor of Pathology and Neurosurgery Director of Microvascular and Molecular Neuro-Oncology Laboratory Chief of Neuropathology Director, Human Brain Tumor Bank NYU Langone Health

* Children’s Brain Tumor Foundation Board ** Honorary Board Member, Children’s Brain Tumor Foundation

Dream & Promise Awards Benefit 2019 | 41

Children’s Brain Tumor Foundation Board of Directors, Professional Advisors and Staff BOARD OF DIRECTORS

PROFESSIONAL STAFF

Lionel Leventhal

Gary D. Jaworski, PhD

Robert M. Budlow

Stacia Wagner, MSW

Miriam R. Barry

Michael Saxe

Leigh Anne Brodsky

Kayla Giacin

Eric S. Snyder

Rena Ben-Ezra

Billy Goldstein

Jessica Elder, LMSW, LCSW-NY

Anita Nirenberg, PhD, RN, FAAN

Kate Shafer, LICSW

Gary Brewster

Regina Karchner, LICSW

Board Chair Treasurer

Secretary

Vice Chair Vice Chair

Vice President Vice President

Christopher Coutts Linda Wachtel, LMSW Akiva Zablocki

HONORARY BOARD MEMBERS

Co-President Co-President

Vice President - Marketing & Partnerships Manager, Quality of Life Programs and Marketing Development Associate Bereavement Program Manager Transition Social Work Manager Social Work Coordinator - West Coast

Stephanie Freeman, LICSW, EdM, OSW-C Social Work Coordinator - East Coast

Brett Sternick

Resource and Research Assistant

Linda Angel Paula Scott Susan L. Weiner, PhD

MEDICAL ADVISOR Joshua B. Rubin, MD, PhD

PRESIDENT’S ADVISORY COUNCIL Stuart M. Essig, PhD Heidi Horsley, PhD Johanna Ramos-Boyer Ginny Shulman Joe Sestak Susan L. Weiner, PhD

Hope for the future. Capital One® Healthcare is proud to support the extraordinary work of the Children’s Brain Tumor Foundation at the 17th annual Dream and Promise Awards Beneﬁt. We’re delighted to recognize the honorees for all they do to improve the lives of children and their families.

capital.one/healthcare

The third parties listed are not aﬃliated with Capital One and are solely responsible for their products and services. Products and services are oﬀered by Capital One, N.A., Member FDIC. © 2019 Capital One. 42 | Dream & Promise Awards Benefit 2019

Dream & Promise Awards Benefit 2019 | 43

Congratulations to the

Children’s Brain Tumor Foundation

Wells Fargo is proud to support the Children’s Brain Tumor Foundation

and especially to our own

Dr. Bernadine Donahue Chair of Radiation Oncology Maimonides Cancer Center

recipient of this year’s

Pioneer Award in Radiation Oncology Kenneth Gibbs President & CEO

Eugene Keilin Chair, Board of Trustees

4802 TENTH AVENUE | BROOKLYN | NY 11219

888.MMC.DOCS (888.662.3627) | 718.283.6000 WWW. MAIMONDESMED.ORG

We believe that children are the future of our society. We believe in supporting the communities we serve. We believe in the power of inspiration and support the participation of our people in causes that make the world better. Thus we are proud to support the Children’s Brain Tumor Foundation and the important work it does every day.

wellsfargo.com/securities © 2019 Wells Fargo Securities, LLC. All rights reserved. PDS-1521585 Wells Fargo Securities is the trade name for the capital markets and investment banking services of Wells Fargo – Company and its subsidiaries, including but not limited to Wells Fargo Securities, LLC, a member of NYSE, FINRA, NFA and SIPC, Wells Fargo Prime Services, LLC, a member of FINRA, NFA and SIPC, and Wells Fargo Bank, N.A. Wells Fargo Securities, LLC and Wells Fargo Prime Services, LLC are distinct entities from affiliated banks and thrifts. Dream & Promise Awards Benefit 2019 | 45

Experience family travel like never before From the moment you board, your young explorers will be kept entertained. With Oryx Kids Club, they can enjoy an in-flight activity pack, personal meal box, and movies and games on the dedicated childrenâ&#x20AC;&#x2122;s channels of Oryx One. Experience family travel like never before.

46 | Dream & Promise Awards Benefit 2019

qatarairways.com

Thank You We extend our deepest appreciation to the following organizations and individuals who gave generously to make this evening a success: B&G Foods, Inc. for donating New York Flatbreads and Back to Nature Granola for each gift bag. Hallmark Cards, Inc. for donating the gift bags. The Hershey Company for donating pouches of Hershey’s Reese’s Milk Chocolate Peanut Butter Cup Thins and Hershey’s Assortment Kisses for each gift bag. Pevonia International, LLC for donating a beauty sample collection for each gift bag. Setton International Foods, Inc. for donating pistachios for each gift bag.

STUDIO 7 MEDIA LLC IS HONORED TO HAVE CO-PRODUCED TONIGHT’S FILM ABOUT BERNADINE R. DONAHUE, MD, TONIGHT’S RECIPIENT OF THE PIONEER AWARD FOR RADIATION ONCOLOGY

We extend our gratitude to the following organizations and individuals who gave generously to make this evening a success: Zainab Al Dabbagh Stacy Amato Elizabeth Anderson Peter Arduini Atlas Floral Decorators Elliot J. Atlas Miriam Barry Rena Ben-Ezra Chris Black George Blaine Leigh Anne Brodsky Michele G. Buck Robert M. Budlow Felicia Burger Laura Capicchioni Joe Chan Cara Cohen Glenn Coleman William W. Compton Copyland Center Lucy Corio Christopher Coutts Jodi Cross Marianna Dattolo Robert T. Davis, Jr. Christian De Matteo Alysha DeNichilo Bernadine R. Donahue, MD Steve Doran Stephen Downey Carmen Dumitriu Natalia Dziopko Richard Eisner Jessica Elder, LMSW, LCSW–NY Sravan K. Emany Stuart M. Essig, PhD

Aryeh Gelbard, Filmmaker

Coralis Vega Anthony G. Viscogliosi John J. Viscogliosi Marc R. Viscogliosi

Judy Famigletti Peter Faris Rebecca Faulkenberry John Fitzpatrick 583 Park Avenue 501 Auctions Mark Flyer, MD Gallery of Graphic Arts Ltd. Aryeh Gelbard Kayla Giacin Naomi Glaser Go Charity Bryan Gonzales Phillipe Hennessy Sylvie Hennessy Jim Horton Dr. John W. & Jeanne M. Hubbard Arielle Jacobs Gary D. Jaworski, PhD Carl Johnson Kelly Kass Melissa S. Kaynas Sam Kopel, MD Lionel Leventhal Lauren Lundquist Maimonides Cancer Center Liz Mandarino Dorian Mecir Yogeswari Medepalli Robert Millham Adina Dovman Mitchell John Mooradian David Moried John Napolitano Sandra Nelson Gary L. Noel, Jr. Brenda Odell Petra Osborne Maggie Piper Sam Phelps Dan Reuvers Joseph P. Riccardo, Jr. Craig M. Robertson Gianna Sabella Eric Sas Michael Saxe Steven Scebelo Peter Scherer Ellen Schum Eric Schwartz Morris Setton Ginny Shulman Jon Simmons Debbie Simonic Michael & Pia Solomon Clare Straatveit

Stacia Wagner, LSW Dorina Wiendl Joanne Wilson Vice Admiral (Ret) Anthony L. Winns Jeffrey H. Wisoff, MD Kimberly Yohn Special thanks to the following organizations and individuals who donated packages for this evening’s auctions: Assorted Gems Corporation Athleta UWS, NYC Atlas Floral Decorators, Inc. Big Apple Circus Blank Rome LLP Darran Brown Cadent Network CBS Delta Airlines Dorian’s Seafood Market FOX Corporation Gainey Suites, AZ Gurney’s Montauk Hershey Entertainment & Resorts Company Hopewell Valley Country Club, Hopewell, NJ ITN Networks Let’s Dress Up! Live with Kelly and Ryan Makefield Highlands Golf Club, Yardley, PA Museum of Illusions NBC Sports Group New York Giants New York Jets New York Mets New York Yankees NFL Players Association Philadelphia Eagles Shibui Spa SoulCycle Tennis Media The Hershey Company The Perfect Gift Turner Sports Universal McCann Valera Global Anthony G. Viscogliosi John J. Viscogliosi Marc R. Viscogliosi World Travel, Inc.

Kevin Tang Patrick Tully Eileen Tynion

www.studio7mediallc.com • 718-252-2933 48 | Dream & Promise Awards Benefit 2019

Dream & Promise Awards Benefit 2019 | 49

Credits Charlotte C. Simon Productions, Inc. Executive Producer Crystal Donkor, PhD Melanie Mohsin Assistants to Charlotte C. Simon Christian De Matteo Writer H Plus Inc. Graphic Design Rose Press Inc. Invitation and Souvenir Journal Printing Steve Doran Production Stage Manager Current Affair Music Reception, Dinner and Awards Show Music Patrick Tully Auctioneer

Film on Bernadine R. Donahue, MD Aryeh Gelbard, Studio 7 Media, LLC, Co-Producer Charlotte C. Simon, Co-Producer Jon Simmons, Videographer Christian De Matteo, Editorial Advisor Eileen Tynion, Maimonides Medical Center Jodi Cross, Maimonides Medical Center Kelly Kass, Maimonides Medical Center

583 Park Avenue Jessica Antunes, Director of Sales, Gala Productions Sage Archipolo, Operations Meagan Hundt, Director of Sales Alison Jasonides, Maitre D’ Hotel Ellen Knowles, Event Sales and Coordinator Jaime Vasquez, Executive Chef

We are proud to support the Children’s Brain Tumor Foundation, and we congratulate them on 31 years of altruistic generosity.

Our warmest thanks to Annette Bozak and Gabriel Weyershaeuser for their participation in this evening’s stage reading. Special thanks to all the volunteers for this evening’s event.

NYC’s premier source for luxury gift baskets We offer a complete selection of gourmet specialties: Kosher, Healthy & Nutritious, Hotel and Party Gifts, Corporate and Custom Orders. Each gift is artistically wrapped in shimmering tulle with an exquisite French Bow and your personal message elegantly inscribed in calligraphy on a beautiful greeting card.

212-541-4438 • www.theperfectgiftny.com 50 | Dream & Promise Awards Benefit 2019

Dream & Promise Awards Benefit 2019 | 51

Thank you!

52 | Dream & Promise Awards Benefit 2019